Beta Thalassemia Transfusion Dependent

Also known as: Transfusion-dependent Beta-Thalassemia / Transfusion Dependent Beta-thalassemia / Transfusion Dependent Beta Thalassemia / Transfusion Dependent Beta-Thalassaemia

DrugDrug NameDrug Description
DB15572Exagamglogene autotemcelAn autologous CRISPR-Cas9 modified hematopoietic stem cell therapy for the treatment of patients with sickle cell disease and recurrent vaso-occlusive crises.
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB01609Deferasirox2Completed1
DB16236Mitapivat3Active Not Recruiting1
DB14546Sulfate ion3Active Not Recruiting1
DB01041Thalidomide3Completed1